Brainstorm Cell Therapeutics Inc.
USD0.90
-0.04 (-4.51%)
CEO
Chaim Lebovits
IPO Date
2003-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.95
Prev. Close
$0.94
Day Low
$0.88
Day High
$0.95
52W Low
$0.46
52W High
$1.69
Market Cap
$0.01B
Volume
0.01M
| 150,000 |
| $0.00 |
| 29 May 2026 | Patlis Alla | See Remarks | A-Award | Acquired | 100,000 | $0.00 |
| 29 May 2026 | FRENKEL JACOB A | director | A-Award | Acquired | 200,000 | $0.00 |
| 29 May 2026 | ARBEL IRIT | director | A-Award | Acquired | 120,000 | $0.00 |
| 29 May 2026 | Lebovits Chaim | President & CEO | A-Award | Acquired | 1,800,000 | $0.00 |
| 20 May 2026 | Bairu Menghisteab | director | A-Award | Acquired | 150,000 | $0.70 |
| 20 May 2026 | Polverino Anthony J. | director | A-Award | Acquired | 150,000 | $0.70 |
| 20 May 2026 | HARTOUNIAN HARTOUN | director | A-Award | Acquired | 225,000 | $0.70 |
| 20 May 2026 | Lindborg Stacy | director | A-Award | Acquired | 150,000 | $0.70 |